Depression and cardiovascular disease

被引:98
作者
Bradley, Steven M. [1 ,2 ,3 ]
Rumsfeld, John S. [1 ,2 ,3 ]
机构
[1] VA Eastern Colorado Hlth Care Syst, Dept Vet Affairs, Denver, CO 80220 USA
[2] Univ Colorado, Sch Med, Div Cardiol, Dept Med, Aurora, CO USA
[3] Colorado Cardiovasc Outcomes Res Consortium, Denver, CO USA
关键词
CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; URINARY NOREPINEPHRINE EXCRETION; SEROTONIN REUPTAKE INHIBITORS; COLLABORATIVE CARE; RATE-VARIABILITY; ARTERY-DISEASE; RISK-FACTOR; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION;
D O I
10.1016/j.tcm.2015.02.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a wealth of evidence linking depression to increased risk for cardiovascular disease (CVD) and worse outcomes among patients with known CVD. In addition, there are safe and effective treatments for depression. Despite this, depression remains under-recognized and undertreated in patients at risk for or living with CVD. In this review, we first summarize the evidence linking depression to increased risk of CVD and worse patient outcomes. We then review the mechanisms by which depression may contribute to cardiovascular risk and poor cardiovascular outcomes. We then summarize prior studies of depression treatment on cardiovascular outcomes. Finally, we offer guidance in the identification and management of depression among CVD populations. Given that 1 in 4 CVD patients has concurrent depression, application of these best-practices will assist providers in achieving optimal outcomes for their CVD patients. Published by Elsevier Inc.
引用
收藏
页码:614 / 622
页数:9
相关论文
共 90 条
  • [1] The prevalence of unrecognized depression in patients with acute coronary syndrome
    Amin, Alpesh A.
    Jones, Angela M. H.
    Nugent, Karen
    Rumsfeld, John S.
    Spertus, John A.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (05) : 928 - 934
  • [2] DEPRESSED AFFECT, HOPELESSNESS, AND THE RISK OF ISCHEMIC-HEART-DISEASE IN A COHORT OF UNITED-STATES ADULTS
    ANDA, R
    WILLIAMSON, D
    JONES, D
    MACERA, C
    EAKER, E
    GLASSMAN, A
    MARKS, J
    [J]. EPIDEMIOLOGY, 1993, 4 (04) : 285 - 293
  • [3] Cytokines, stress and depressive illness: brain-immune interactions
    Anisman, H
    Merali, Z
    [J]. ANNALS OF MEDICINE, 2003, 35 (01) : 2 - 11
  • [4] Ariyo AA, 2000, CIRCULATION, V102, P1773
  • [5] BALOGH S, 1993, PSYCHOPHARMACOL BULL, V29, P201
  • [6] Elevated brain serotonin turnover in patients with depression
    Barton, David A.
    Esler, Murray D.
    Dawood, Tye
    Lambert, Elisabeth A.
    Haikerwal, Deepak
    Brenchley, Celia
    Socratous, Florentia
    Hastings, Jacqueline
    Guo, Ling
    Wiesner, Glen
    Kaye, David M.
    Bayles, Richard
    Schlaich, Markus P.
    Lambert, Gavin W.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (01) : 38 - 46
  • [7] Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?
    Barton, David A.
    Dawood, Tye
    Lambert, Elisabeth A.
    Esler, Murray D.
    Haikerwal, Deepak
    Brenchley, Celia
    Socratous, Florentia
    Kaye, David M.
    Schlaich, Markus P.
    Hickie, Ian
    Lambert, Gavin W.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (10) : 2117 - 2124
  • [8] Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
  • [9] SEROTONIN 5-HT2 RECEPTOR-BINDING ON BLOOD-PLATELETS AS A STATE DEPENDENT MARKER IN MAJOR AFFECTIVE-DISORDER
    BIEGON, A
    ESSAR, N
    ISRAELI, M
    ELIZUR, A
    BRUCH, S
    BARNATHAN, AA
    [J]. PSYCHOPHARMACOLOGY, 1990, 102 (01) : 73 - 75
  • [10] Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease
    Bonnet, F
    Irving, K
    Terra, JL
    Nony, P
    Berthezène, F
    Moulin, P
    [J]. ATHEROSCLEROSIS, 2005, 178 (02) : 339 - 344